Susan Combs Scott, M.D.

Headshot of Susan Combs Scott
  • Assistant Professor of Oncology

Languages: English, Spanish


Lung Cancer, Mesothelioma, Neuroendocrine Tumors, Non-Small Cell Lung Cancer, Pulmonary Carcinoid Tumors, Small Cell Lung Cancer, Thymic Carcinoma more

Research Interests

Lung Cancer; Clinical Trials; Early Stage Lung Cancer; EGFR more


Sibley Memorial Hospital

5255 Loughboro Road NW
Johns Hopkins Kimmel Cancer Center
Washington, DC 20016 map
Phone: 202-660-6500 | Fax: 202-660-6501

The Johns Hopkins Hospital

600 N. Wolfe Street
Baltimore, MD 21287 map
Phone: 410-955-7893 | Fax: 410-955-0548


Dr. Susan Scott is a thoracic medical oncologist with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital and Assistant Professor of Oncology at the Johns Hopkins University School of Medicine. Dr. Scott has expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and pulmonary carcinoid tumors, as well as thymic malignancies.

Dr. Scott received her undergraduate education at the University of Oxford, UK and medical doctorate from Yale University. She completed residency at the Cleveland Clinic where she also served as Chief Resident in Internal Medicine. Dr. Scott joined Johns Hopkins Oncology for fellowship training in Baltimore and was recruited to the thoracic oncology program to continue work as a physician and clinical scientist focused in lung cancer.

Dr. Scott and her team are committed to providing compassionate and individualized care to their patients, including state-of-the-art therapies and clinical trials. Her research interests include clinical trials in resectable lung cancer, innovative applications of immunotherapy, and novel targeted therapies, including EGFR-mutated lung cancer. Dr. Scott is a member of the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and the International Association for the Study of Lung Cancer (IASLC). more


  • Assistant Professor of Oncology

Departments / Divisions

  • Medicine at Sibley Memorial Hospital
  • Oncology - Upper Aerodigestive Cancer

Centers & Institutes



  • MD; Yale School of Medicine (2015)


  • Internal Medicine; Cleveland Clinic Foundation (2018)


  • Hematology and Medical Oncology; Johns Hopkins University School of Medicine (2021)

Board Certifications

  • American Board of Internal Medicine (Internal Medicine) (2018)
  • American Board of Internal Medicine (Oncology) (2021)

Research & Publications

Technology Expertise Keywords

Lung Cancer; Clinical Trials; Early Stage Lung Cancer; EGFR

Selected Publications

View all on PubMed

Scott SC, Hann CL. Immunotherapy for small cell lung cancer: established applications and novel approaches. Clin Adv Hematol Oncol. 2021 Oct; 19 (10) :654-663

Guo MZ, Marrone KA, Spira A, Waterhouse DM, Scott SC. Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics. Onco Targets Ther. 2021;14:5321-5331

Scott SC, Pennell NA. Early Use of Systemic Corticosteroids in Patients with Advanced NSCLC Treated with Nivolumab. J Thorac Oncol. 2018 Nov;13(11):1771-1775

Scott SC, Lee SS, Abraham J. Mechanisms of therapeutic CDK4/6 inhibition in breast cancer. Semin Oncol. 2017 Dec;44(6):385-394

Combs SE, Hancock JG, Boffa DJ, Decker RH, Detterbeck FC, Kim AW. Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base. J Thorac Oncol. 2015 Feb;10(2):316-23

Videos & Media

Recent News Articles and Media Coverage

What is EGFR-Positive Lung Cancer?, WebMD

How EGFR-Positive Lung Cancer Is Treated, WebMD

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button